- Home
- IMMX vs CPBI Comparison
IMMX vs CPBI Comparison
Compare IMMX & CPBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- CPBI
- Stock Information
- Founded
- IMMX 2014
- CPBI 2023
- Country
- IMMX United States
- CPBI United States
- Employees
- IMMX N/A
- CPBI N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- CPBI
- Sector
- IMMX Health Care
- CPBI
- Exchange
- IMMX Nasdaq
- CPBI Nasdaq
- Market Cap
- IMMX 61.1M
- CPBI 53.6M
- IPO Year
- IMMX 2021
- CPBI N/A
- Fundamental
- Price
- IMMX $2.17
- CPBI $15.17
- Analyst Decision
- IMMX Strong Buy
- CPBI
- Analyst Count
- IMMX 1
- CPBI 0
- Target Price
- IMMX $7.00
- CPBI N/A
- AVG Volume (30 Days)
- IMMX 269.5K
- CPBI 7.6K
- Earning Date
- IMMX 11-12-2024
- CPBI 01-01-0001
- Dividend Yield
- IMMX N/A
- CPBI N/A
- EPS Growth
- IMMX N/A
- CPBI N/A
- EPS
- IMMX N/A
- CPBI 0.89
- Revenue
- IMMX N/A
- CPBI $18,262,000.00
- Revenue This Year
- IMMX N/A
- CPBI N/A
- Revenue Next Year
- IMMX $200.00
- CPBI N/A
- P/E Ratio
- IMMX N/A
- CPBI $16.96
- Revenue Growth
- IMMX N/A
- CPBI 37.54
- 52 Week Low
- IMMX $1.26
- CPBI $9.80
- 52 Week High
- IMMX $7.50
- CPBI $15.46
- Technical
- Relative Strength Index (RSI)
- IMMX 53.37
- CPBI 65.98
- Support Level
- IMMX $1.88
- CPBI $14.19
- Resistance Level
- IMMX $2.44
- CPBI $14.52
- Average True Range (ATR)
- IMMX 0.32
- CPBI 0.25
- MACD
- IMMX -0.02
- CPBI 0.01
- Stochastic Oscillator
- IMMX 34.94
- CPBI 77.17
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.